New Delhi, India

Ram A Vishwakarma

This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Immunology. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ram A Vishwakarma. Retrieved from https://idiyas.com/inventor/ram-a-vishwakarma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ram A Vishwakarma: Innovator in Immunomodulatory Compounds

Introduction

Ram A Vishwakarma is a notable inventor based in New Delhi, India. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the isolation and synthesis of compounds that have potential therapeutic applications.

Latest Patents

Ram A Vishwakarma holds a patent for a process that involves the isolation and synthesis of 1-(3,4-methylenedioxy-phenyl)-1E-tetradecene from Piper longum. This patent outlines processes for synthesizing not only the primary compound but also its stereoisomers and analogues. The compounds developed through this invention exhibit immunomodulatory properties, making them valuable for treating tumors and infections. He has 1 patent to his name.

Career Highlights

Ram A Vishwakarma is affiliated with the National Institute of Immunology, where he conducts his research. His work has contributed to advancements in the understanding of immunomodulatory compounds and their applications in medicine.

Collaborations

He has collaborated with notable colleagues such as Shakti N Upadhyay and Sabari Ghosal, further enhancing the impact of his research in the scientific community.

Conclusion

Ram A Vishwakarma's innovative work in the field of immunology highlights the importance of research in developing new therapeutic compounds. His contributions continue to pave the way for advancements in treating various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…